SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces First Quarter 2024 Results
May 13, 2024 09:15 ET | Sanara MedTech Inc.
FORT WORTH, TX, May 13, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
May 10, 2024 14:43 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates
April 29, 2024 09:15 ET | Sanara MedTech Inc.
FORT WORTH, TX, April 29, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
April 10, 2024 09:00 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
April 09, 2024 09:05 ET | NeuroOne Medical Technologies Corp
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control EDEN PRAIRIE,...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.
April 04, 2024 09:00 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., April 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
March 26, 2024 09:00 ET | NeuroOne Medical Technologies Corp
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control Limited...
SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
March 25, 2024 16:05 ET | Sanara MedTech Inc.
FORT WORTH, TX, March 25, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
NO16 NEUROONE LOGO_RGB.png
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 23, 2024 17:10 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
February 22, 2024 09:15 ET | Sanara MedTech Inc.
FORT WORTH, TX, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...